Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) — Strategic Asset Allocation Index
Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a Strategic Asset Allocation Index of 18.0% as of June 2023. Strategic assets (PP&E of CN¥2.41 Billion plus long-term investments of CN¥-) total CN¥2.41 Billion, measured against net assets of CN¥13.39 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 603392 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 18.0%, representing strategic assets of CN¥2.41 Billion against net assets of CN¥13.39 Billion CNY. See 603392 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Beijing Wantai Biological Pharmacy Enter.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 17.8% | CN¥2.24 Billion | CN¥2.24 Billion | CN¥- | CN¥12.56 Billion | ▼ -19.5 pp |
| 2021 | 37.3% | CN¥1.70 Billion | CN¥1.70 Billion | CN¥- | CN¥4.56 Billion | ▲ +6.7 pp |
| 2020 | 30.7% | CN¥790.98 Million | CN¥790.98 Million | CN¥- | CN¥2.58 Billion | ▼ -9.1 pp |
| 2019 | 39.7% | CN¥627.70 Million | CN¥627.70 Million | CN¥- | CN¥1.58 Billion | ▼ -2.9 pp |
| 2018 | 42.7% | CN¥584.53 Million | CN¥584.53 Million | CN¥- | CN¥1.37 Billion | ▼ -20.8 pp |
| 2017 | 63.5% | CN¥570.55 Million | CN¥570.55 Million | CN¥- | CN¥898.99 Million | ▲ +26.6 pp |
| 2016 | 36.9% | CN¥354.02 Million | CN¥354.02 Million | CN¥- | CN¥959.70 Million | — |